These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
18. A Phase II Trial of Concurrent Temozolomide and Hypofractionated Stereotactic Radiotherapy for Complex Brain Metastases. Bi N; Ma Y; Xiao J; Zhang H; Xu Y; Tian Y; Li J; Zhang Y; Liu Q; Wang K; Deng L; Wang W; Chen X; Liu F; Zhao R; Yang S; Huang X; Yi J; Hu C; Li Y Oncologist; 2019 Sep; 24(9):e914-e920. PubMed ID: 30996008 [TBL] [Abstract][Full Text] [Related]
19. Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy. Dincoglan F; Beyzadeoglu M; Sager O; Demiral S; Gamsiz H; Uysal B; Ebruli C; Akin M; Oysul K; Sirin S; Dirican B Tumori; 2015; 101(2):179-84. PubMed ID: 25791534 [TBL] [Abstract][Full Text] [Related]
20. Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control. Meniai-Merzouki F; Bernier-Chastagner V; Geffrelot J; Tresch E; Lacornerie T; Coche-Dequeant B; Lartigau E; Pasquier D Sci Rep; 2018 Sep; 8(1):13666. PubMed ID: 30209337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]